We are live on ! Find out more
DRIOW

DarioHealth Corp. Warrant

Delisted

DRIOW was delisted on the 4th of March, 2021.

3 hedge funds and large institutions have $2K invested in DarioHealth Corp. Warrant in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 23 (+1)

82% less capital invested

Capital invested by funds: $11K → $2K (-$9K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$6.15K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$1.16K
2
BA
Bard Associates
Illinois
-$117
Name Holding Trade Value Shares
Change
Change in
Stake
BA
1
Bard Associates
Illinois
$1K -$117 -1,000 -2%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$1K +$6.15K +52,667 New
UBS Group
3
UBS Group
Switzerland
-$1.16K -9,900 -57%

DRIOW Hedge Fund Activity: Q4 2018 in Review

3 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in DarioHealth Corp. Warrant (DRIOW) for Q4 2018, worth a combined $2K — down 82% from $11K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new DRIOW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $6.15K. The largest seller was UBS Group, cutting an estimated $1.16K.

  • 3 institutional investors held DarioHealth Corp. Warrant (DRIOW) as of Q4 2018, up from 2 in Q3 2018.
  • Funds reported $2K of DarioHealth Corp. Warrant stock for Q4 2018, down 82% quarter-over-quarter.
  • 1 fund opened new DarioHealth Corp. Warrant positions in Q4 2018 and 0 closed out, a net change of +1 holder.
  • The largest DarioHealth Corp. Warrant buyer in Q4 2018 was Susquehanna International Group, an estimated $6.15K added.
  • The largest DarioHealth Corp. Warrant seller in Q4 2018 was UBS Group, an estimated $1.16K sold.

Based on aggregated 13F filings for Q4 2018.